Results of studies of hypophysectomized rats suggest that growth hormone serves as a final common mediator through which gonadal steroids and other modifiers of pituitary function alter the expression of gender-specific liver genes such as the sexually dimorphic pair of cytochrome P-450 isozymes, male-specific P-450h and female-specific P-450i. We tested the effects of growth hormone in a system for primary monolayer culture of adult rat hepatocytes on a laminin-rich extracellular matrix (matrigel), which permits sustained expression of both constitutive and inducible liver genes in a chemically defined medium. Cultures of freshly isolated hepatocytes prepared from untreated male rats and samples of the intact donor liver contained readily detectable quantities of immunoreactive P-450h protein (measured on immunoblots of cell microsomes) and P-450h mRNA (measured on Northern blots of cellular RNA). Neither P-450i immunoreactive protein nor P-450i mRNA were present. Addition of physiologic concentrations of human or bovine growth hormone, but not of prolactin, to culture medium lacking insulin or other hormones resulted in prompt induction of P-450i immunoreactive protein and P-450i mRNA. Induction of P-450i mRNA in male hepatocyte cultures was dependent on the concentration of growth hormone, required as little as 24 hr of exposure, and was markedly attenuated in cultures maintained on type I collagen rather than on matrigel. Growth hormone treatment also induced the level of mRNA for insulin-like growth factor I, whereas the amount of mRNA for the male-specific urinary protein a2gA-globulin was unaffected. Cultures of hepatocytes derived from untreated adult female rats retained high levels of P-450i mRNA but only if the culture medium contained growth hormone. None of the tested treatments with estrogens, androgens, glucocorticoids, or growth hormone induced P-450h mRNA or P-450h immunoreactive protein in cultures of female hepatocytes. We conclude that the somatogenic effects of growth hormone acting alone and directly on the hepatocyte in culture are sufficient to "feminize" the cytochrome P-450 phenotype. The present culture system offers a way to explore the molecular basis for hormonal control of liver gene expression.
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Numerous liver-specific genes exhibit a complex, hormonally influenced pattern of developmental expression that culminates in a striking qualitative sexual dimorphism, particularly in adult rodents (1, 2) . Typical of this phenomenon is the gender-specific expression of certain members of the class IIC gene family (3) of the cytochromes P-450, a group of microsomal hemoproteins that catalyze the oxidation of many drugs, environmental pollutants, and endogenous lipophilic substrates. Liver P-450h, often monitored by its androgen 2a-or 16a-hydroxylase activity is expressed predominantly in adult male rats, whereas P-450i, the 15p3-hydroxylase of sulfate steroids, is found predominantly in adult female rats (4) (5) (6) (7) . Because exposure of neonatal rats to androgen is critical for the sex-specific developmental expression of P-450h and because treatment of adult rodents with gonadal steroids can alter the gender-specific expression of these cytochromes (8) (9) (10) , it has been proposed that steroid hormone receptors in the liver may control sexual dimorphism (1) . However, strong evidence has accumulated over the last several years supporting the idea that growth hormone serves as a final common mediator through which diverse influences on the hypothalamic-pituitary axis affect sex-specific gene expression in the liver (6) . For example, if hypophysectomized rats ofeither sex are infused with human growth hormone continuously to mimic the sustained release of growth hormone as is characteristic of female rats, the cytochrome P-450 phenotype becomes "feminized" (2) . Levels of P-450i rise and those of P-450h fall (11) . If intermittent, subcutaneous injections of human growth hormone are given to simulate the pulsatile pattern of release as is characteristic of male rats, the inverse masculine phenotype of cytochromes P-450 is observed (8) . Inasmuch as treatment of adult animals with gonadal steroids alters the sex-specific pattern of growth hormone release (12) , these sex steroids could be affecting liver function indirectly by acting through the pituitary. Unfortunately, the classical endocrinologic approach of organ ablation and hormonal replacement in animals in vivo is not well suited to definitely establish which hormones act directly on the liver.
In theory, the system of primary monolayer cultures of adult rat hepatocytes should be ideal for examining the effects of growth hormone on the liver cytochromes P-450. In our standard system, hepatocytes can be maintained in a serum-free, chemically defined medium on collagen-coated plastic dishes for many days while numerous liver-specific functions are expressed, including detectable amounts of P-450h (13) . Similar cultures specifically bind and degrade human growth hormone (14) and respond to its presence with production of somatomedin/insulin-like growth factor (IGF) I protein (15, 16) and mRNA (17) as is observed in the liver of growth hormone-treated mice (18) or rats (19) . However, hepatocyte cultures do not survive in medium lacking insulin, a hormone that can mimic the molecular effects of growth hormone in the liver (20 (21) , inhibition of tyrosine aminotransferase activity (22, 23) , and induction of microsomal 5a-reductase activity (24) , glucose transport (25) , malic enzyme (23) , and specific unidentified proteins (26, 27) . A more serious problem is that not all forms of liver cytochrome P-450, including P-450i, are expressed in our standard hepatocyte cultures (13) .
Recently, we developed a new system for culture of hepatocytes in which matrigel, a reconstituted basement membrane prepared by salt extraction of the EngelbrethHolm-Swarm sarcoma, is substituted as the substratum for cell attachment in place of type I collagen. Matrigel, which is rich in laminin, type IV collagen, and heparan sulfate proteoglycans (28) , remarkably enhances the expression of differentiated liver-speciflic genes in cultured hepatocytes (29) . For example, when hepatocytes cultured on matrigel are treated with phenobarbital, P-450b and P-450e proteins and mRNAs (members of the class IIB gene family) are induced to levels in the same range as those found in phenobarbitaltreated rat liver (29) 1 . Effect of growth hormone and insulin on the expression of various mRNAs in cultures of male hepatocytes maintained on matrigel. Freshly isolated hepatocytes prepared from an untreated male rat were inoculated on dishes precoated with matrigel and were incubated for up to 5 days in medium containing no hormones, insulin (I) alone (0.15 ,uM), human growth hormone (GH) alone (8800 ng/ml), or the combination of insulin and growth hormone. On the indicated days (1, 3, 4, and 5), cells were harvested and samples of hepatocyte RNA were isolated from the cultures and were analyzed on Northern blots hybridized with one of the indicated cDNA probes [P-450i, IGF-I, P-450h, or a2j±-globulin (a-2,)]. Samples of RNA obtained from untreated male or female rat liver are included in the first two lanes for reference. (A minor signal in male mRNA observed in some hybridizations with P-450i cDNA depended on stringency of the conditions and, thus, likely represents cross-reaction with its homologue, P-450h mRNA). After the blot was hybridized with one of the cDNA probes, it was washed and reanalyzed with subsequent probes. Hence, the indicated results represent separate autoradiographs of multiple analyses of the same RNA samples.
of the presence or absence of insulin in the culture medium (Fig. 1) . The appearance of P-450i mRNA was accompanied by induction of immunoreactive protein following growth hormone treatment (Fig. 2) . The presence of insulin appeared to augment the levels of P-450i mRNA ( Fig. 1 ) and immunoreactive protein (Fig. 2) in growth hormone-treated cells. This enhancement by insulin of immunoreactive P-450i was not consistently observed in subsequent experiments (data not shown). In all cases, however, there was always an absolute requirement for growth hormone in the expression of P-450i immunoreactive protein and mRNA.
We initially tested a dose ofgrowth hormone (10 milliunits/ ml or 8800 ng/ml) substantially higher than the 20-500 ng/ml observed in rat serum (12, 40) . Nevertheless, we found from dose-response experiments (similar to those described in Figs. 1 and 2 ) in cultures of male hepatocytes that maximum induction of P-450i mRNA at day 4 was achieved with a concentration of 10 ng/ml of human growth hormone (results not shown). Induction of P-450i mRNA and protein could be eq..
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Irmo detected within 24 hr after starting growth hormone treatment except during the 0-to 48-hr period of culture age ( Fig. 1 and other data not shown). Induction of other forms of cytochrome P-450 we have studied (30, 41) also is impaired during this "unresponsive" period of primary culture possibly due to disturbances in heme metabolism. Growth hormone also was effective in maintaining the adult levels of P-450i protein (results not shown) and P450i mRNA in cultured hepatocytes prepared from female rats (Fig. 3) . In contrast, when cultures of female hepatocytes were maintained in standard medium, P-450i mRNA levels declined to low levels comparable to those found in adult male rat liver (Fig. 3) . Even when exposure of these female cultures to growth hormone was restricted to 8 out of every 24 hr daily for 4-5 days, a concentration of 88 ng/ml was sufficient to partially prevent the disappearance of P-450i mRNA (Fig. 3) . However, none of the protocols for intermittent treatment of female hepatocyte cultures with growth hormone produced induction of P-450h protein or P-450h mRNA (results not shown).
We made direct comparisons between our previous culture system and the one described in this paper by incubating male hepatocytes attached to type I collagen (commercially available as Vitrogen) or matrigel with medium containing growth hormone. Induction of P-450i mRNA was barely detectable in cells on Vitrogen incubated in medium containing insulin plus a high dose of growth hormone (Fig. 4) . When the culture medium contained growth hormone in the absence of insulin, P-450i mRNA appeared only in matrigel cultures (Fig. 4) . Treatment with insulin alone failed to induce P-450i mRNA in male hepatocytes attached to either culture substratum (data not shown).
Specificity of the somatogenic properties of growth hormone was inferred from the observations that bovine growth hormone, which lacks the lactogenic effects of human growth hormone, induced P-450i mRNA in cultures of male rat hepatocytes on matrigel, whereas the same cultures failed to respond to up to 200 milliunits of prolactin per ml (Fig. 5) . Even though growth hormone induced IGF-I mRNA in male hepatocyte culture (Fig. 1) , neither IGF-I nor IGF-II, when added to the culture medium in either the presence or absence of insulin, was capable of inducing P-450i mRNA (Fig. 5) . The effect of growth hormone and insulin on the expression of immunoreactive cytochrome P-450i in cultures of male rat hepatocytes maintained on matrigel. From the experiment described in Fig. 1, cells progesterone, 5a-dihydrotestosterone, 17a-methyltestosterone, and dexamethasone, each at 10 jLM induced P-450i mRNA or P-450h in female hepatocytes on matrigel (data not shown).
DISCUSSION
Our results conclusively demonstrate regulation of a sexspecific form of rat liver cytochrome P-450 by growth hormone alone in direct contact with hepatocytes. This remarkable change in sexual phenotype of male hepatocytes by growth hormone was dose dependent, occurred promptly, and exhibited selectivity among cytochromes P-450 and other liver functions. Our findings in cultured hepatocytes suggest that sexual dimorphism is a reversible phenomenon dependent on continuous exposure to growth hormone, a conclusion entirely consistent with reversible expression of sexual phenotype of cytochromes P-450 in hypophysectomized rats infused with growth hormone in vivo (8, 11 (9) or mice (10) induces male-specific liver androgen 16a-hydroxylase cytochromes P-450, and addition of androgen to isolated, perfused rat liver induces a2p -globulin (40) . It has been suggested that these gonadal steroids could act directly on the liver through specific receptors and induce at least some of the sexually dimorphic cytochromes P-450 (1 (20) . These early events may culminate in an altered pattern of liver gene expression including, presumably, induction of P-450i.
We were unable to induce P-450h in female hepatocytes and thus "masculinize" these cells by treatments with growth hormone or gonadal steroids. Possibly, we have not yet identified the precise growth hormone concentration and duration of hepatocyte exposure that sufficiently mimics in culture the pulsatile pattern of growth hormone release observed in male rats in vivo (2) . It is also possible that induction of P-450h in female cells may require other hormonal factors (46) acting in concert with growth hormone or IGF-I.
It is clear that the use of matrigel permits robust expression of many liver-specific genes, including P-450i, that are either Proc. Natl. Acad. Sci. USA 85 (1988) .Aula&, i1w," not expressed at all or are markedly attenuated in hepatocyte cultures where type I collagen is the substratum. The mechanism for the remarkable effect of matrigel to alter the nutritional and hormonal requirements of the culture medium and to expand the number of differentiated functions carried out by hepatocytes and other cell types in culture (28) is unknown. Binding of cell surface receptors to matrix components in the matrigel may alter cell shape, nuclear shape, or chromatin structure (29) . Matrigel also contains such membrane active molecules as heparan sulfate proteoglycans, which have been championed as specific mediators of gene transcription in hepatocyte cultures (47) . Regardless of the mechanism(s), the matrigel effect does not extend universally to expression ofall cytochromes P-450 since we have not yet identified conditions that permit induction of P-450h (this work) or of the ethanol-inducible cytochrome P-450j (C. Hunt, personal communication). Nevertheless, the matrigel system affords a unique opportunity not only to study the hormonal control of cytochrome P-450 but also to examine structure-activity relationships for growth hormone function. Currently available systems for testing the properties of growth hormone-related polypeptides involve continuously dividing fibroblast cultures that require a serum-containing medium in which insulin can mimic growth hormone actions (45) . The hepatocyte culture system on matrigel involves induction of P-450i in nondividing cells, which can be maintained at least for several days in a serum-free medium devoid of all hormones including insulin. This hepatocyte culture system may offer additional ways to test synthetically prepared growth hormone derivatives for somatogenic effects as well as to explore complex hormonal interactions.
